CVS Health Co. (NYSE:CVS) Shares Sold by MADDEN SECURITIES Corp

MADDEN SECURITIES Corp trimmed its holdings in shares of CVS Health Co. (NYSE:CVSFree Report) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,421 shares of the pharmacy operator’s stock after selling 350 shares during the period. MADDEN SECURITIES Corp’s holdings in CVS Health were worth $1,390,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CVS. Atticus Wealth Management LLC grew its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. USA Financial Formulas boosted its position in CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares during the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health during the fourth quarter valued at about $32,000. Creekmur Asset Management LLC purchased a new stake in shares of CVS Health during the fourth quarter worth about $34,000. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of CVS Health in the fourth quarter worth about $36,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at CVS Health

In other news, Director Edward J. Ludwig acquired 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 0.24% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Cantor Fitzgerald restated a “neutral” rating and set a $58.00 price objective on shares of CVS Health in a report on Wednesday, June 12th. UBS Group cut shares of CVS Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. TD Cowen lowered shares of CVS Health from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $99.00 to $59.00 in a report on Tuesday, May 7th. The Goldman Sachs Group cut their target price on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Finally, JPMorgan Chase & Co. decreased their price target on CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Eleven equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $75.05.

Get Our Latest Stock Report on CVS Health

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.01 on Thursday, hitting $61.00. The company’s stock had a trading volume of 6,897,889 shares, compared to its average volume of 12,068,604. The company has a market capitalization of $76.58 billion, a price-to-earnings ratio of 10.72, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The stock’s 50-day moving average is $60.79 and its two-hundred day moving average is $70.78.

CVS Health (NYSE:CVSGet Free Report) last announced its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the prior year, the company earned $2.20 EPS. The business’s quarterly revenue was up 3.7% on a year-over-year basis. On average, equities research analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with's FREE daily email newsletter.